Comparación del efecto tocolítico, in vitro, entre un anticálcico (nifedipina) versus un ß-agonista(terbutalina) en útero de rata. Estudio descriptivo. Informe preliminar

Quilligan EJ., Little AB., Oh W., Catz C., Alexander D., Cornblath M. An evaluation and assessment of the state of the science. In: Pregnancy birth and the infant. Bethesda, Maryland: National Institutes of Health 1981 ; NIH publication No. 82-02304.

Read MD., Wellby DE., The use of a calcium antagonist (nifedipine) to suppress preterm labour. Br. J. Obstet. Gynecol. 1986; 93: 933-937.

Ingemarsson I . Effect of terbutaline on premature labor: A double-blind placebo-controlled study. Am. J. Obstet. Gynecol. 1976; 125: 520.

Csapo AI., Herczeg J., Arrest of premature labor by isoxsuprine. Am. J. Obstet. Gynecol. 1977; 129: 482.

Wesselius-deCasparis A., Thiery M., Yo Le Sian A. et al. Results of double-blind, multicentre study with ritodrine in premature labor. Br. Med. J. 1971; 3: 144.

Caritis S., Darby M., Chao L. Tratamiento farmacológico del parto pretérmino. Clínicas Obstétricas y Ginecológicas. Ed. Interamericana S.A. México D.F. 1989; 613-622.

Benedetti JT. Maternal complications of parenteral beta-sympaticomirnetic therapy for premature labor. Am. J. Obstet. Gynecol. 1983; 145: 1-6.

Ferguson O JE., Schutz T., Pershe R. et al. Nifedipine pharmacokinetics during preterm labor tocolysis . Am. J. Obstet. Gynecol. 1989; 161: 1485-1490.

Bolton TB. Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rew 1979; 59: 606-692 .

Ulmsten U. Treatment of normotensive and hypertensive patients with preterm labor using oral nifedipine, a calcium antagonist. Arch . Gynecol. 1984; 236: 69-72.

Ferguson II JE., Dyson OC., Holbrook RH. et al. Cardiovascular and metabolic effects associated with nifedipine and ritodrine tocolysis. Am. J. Obstet. Gynecol. 1989; 161: 788-795.

Alexandrova M., Soloff MS. Oxytocin receptors and parturiton. I. Control of oxytocin receptor concentration in the rats myometrium at term. Endocrinology 1980; 106: 730.

Alexandrova M. , Soloff MS. Oxytocin receptors and parturiton. II. Concentrations of receptors for oxytocin and estrogen in the gravid and non gravid uterus at term. Endocrinology 1980; 106: 736.

Carsten M. , Jordan DM. A new 1ook at uterine muscle contraction. Am. J. Obstet. Gynecol. 1987; 157: 1303-1315.

Caldeyro-Barcia R., Poseiro JJ., Theobald GW. Sensitivity of the pregnant human myometrium to oxytocin. Am. J. Obstet. Gynecol. 1968; 102: 1181.

Fuchs A-R., Periyasamy S. , Alexandrova M., Soloff MS. Correlation between oxytocin receptor concentration and responsiveness to oxytocin in pregnant rats myometrium: effects of ovarian steroids. Endocrinology 1983; 113: 742.

Nissenson R. , Flouret G. , Hechter O. Opposing effects of estradiol and progesterone on oxytocin receptors in rabbit uterus. Proc . Natl. Acad. Sci. USA. 1978; 75: 2044.

Pritchard J ., Macdonald P., Gant N. Williams Obstetricia. Ed. Salvat S. A. 3a. ed . México D.F. (Reimpresión) 1989; 302.

Casper R., Lye S. Myometrial desensitization to continuous but not lo intermittent ß 13-adrenergic agoni st infusion in the sheep. Am. J. Obstet. Gynecol. 1986; 154: 301-305.

Spatling L. , Fallenstein F., Schneider H. et al. Bolus tocolysis: Treatment of preterm labor with pulsatile administration of a ß-adrenergic agonist. Am. J . Obstet. Gynecol. 1989; 160: 7 13-717.

Caritis S. , Edelstone D., Mueller-Heubach E. Pharmacologic inhibition of preterm labor. Am. J . Obstet. Gynecol. 1979; 133: 557.

Caritis S. Treatment of preterm labour: a review of therapeutic options. Drugs 1983; 26: 243.

Hendricks SK. , Keroes J., KAtz M. Electrocardiographic changes associates with ritodrine-induced maternal tachycardia and hypocalemia. Am. J. Obstet. Gynecol. 1986; 154: 921.

Ingemarsson I., Bengtsson B. A five-year experience with terbutaline for preterm labor: low rate for severe side effects. Obstet. Gynecol. 1985; 66: 176.

Formann A., Andersson K-E., Persson C., Ulmsten U. Relaxant effects of nifedipine on insolated, human myometrium. Acta Pharmaol Toxicol 1979; 45: 81-86.

Anderson K-E., Ingemarsson I., Ulmsten U., Wingerup L. Inhibition of prostaglandin-induced uterine activity by nifedipine. Br. J . Obstet. Gynecol. 1979; 86: 175-179.

Forman A., Gandrup P., Andersson K-E., Ulmsten U. Effects of nifedipine of oxytocine and prostaglandin F2alfa induced activity in the post-partum uterus . Am. J. Obstet. Gynecol. 1982; 144:665-670.

Ulmsten U., Andersson K-E, Wingerup L. Treatment of premature labor with the calcium antagonist nifedipine. Arch. Gynecol. 1980; 229: 1 .

Harake B., Gilbert R., Ashawal S., Power G. Nifedipine: Effects on fetal and maternal hemodynamics in pregnant sheep. A m J. Obstet. Gynecol. 1987; 157: 1003- 1008.

Lirette M., Holbrook RH., Katz M. Cardiovascular and uterine blood flow changes during nicardipine HCL tocolysis in the rabbit. Obstet. Gynecol. 1987; 69: 79 .

Veille JC., Bissonnette JM., Hohimer AR. The effect of a calcium channel blocker (nifedipine) on uterine blood flow in the pregnantgo'at. Am. J . Obstet. Gynecol. 1986; 154: 1160.